Silk Road Medical Shares Surge Premarket on Boston Scientific Deal
Provided by
Dow Jones
By Colin Kellaher
Shares of Silk Road Medical rose sharply in premarket trading Tuesday after the medical-device maker agreed to be acquired by larger peer Boston Scientific for about $1.26 billion.
Boston Scientific is paying $27.50 a share in cash for Silk Road, a 27% premium to Monday's closing price of $21.67 for the Sunnyvale, Calif., company.
Silk Road shares were recently changing hands at $26.60, up nearly 23%, in premarket trading.
The deal, which carries an enterprise value of about $1.16 billion including Silk Road's cash position, is slated to close by the end of the year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 18, 2024 07:41 ET (11:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
United States